Arndt Vogel
@arndtvogel
Clinician-Scientist, ESMO Ambassador, focussed on Liver Cancer & Precision Oncology, Toronto General Hospital/Princess Margaret Cancer Center 🇨🇦/MHH🇩🇪
ID: 1211086357
23-02-2013 08:40:33
1,1K Tweet
7,7K Takipçi
578 Takip Edilen
🔥CHMP recommended a conditional marketing authorisation for zanidatamab for the treatment of HER2-positive biliary tract cancer🔥 👉based on HERIZON-BTC: ORR 41% 👉Phs-III in 1st line ongoing ESMO - Eur. Oncology EASL Education ILCA Cholangiocarcinoma Foundation @livertwitter
